Edition:
United Kingdom

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

255.00SEK
19 Feb 2018
Change (% chg)

-3.80kr (-1.47%)
Prev Close
258.80kr
Open
262.80kr
Day's High
262.80kr
Day's Low
254.00kr
Volume
61,961
Avg. Vol
160,538
52-wk High
290.00kr
52-wk Low
96.75kr

Chart for

About

Hansa Medical AB is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection. The Company’s operations consist of research and development for drug discovery. The Company conducts several projects, among which... (more)

Overall

Beta: 1.83
Market Cap(Mil.): kr7,554.32
Shares Outstanding(Mil.): 35.05
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.64
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Hansa Medical Granted Orphan Drug Designation By FDA

* HANSA MEDICAL RECEIVES FDA ORPHAN DRUG DESIGNATION FOR IDES AND THE TREATMENT OF GUILLAIN-BARRÉ SYNDROME Source text for Eikon: Further company coverage: (Gdynia Newsroom)

16 Feb 2018

BRIEF-Hansa Medical AB Q4 Net Revenue Sek 1.0 ‍​ Million Versus Sek 0.5 Million Year Ago

* Q4 NET REVENUE SEK 1.0 ‍​ MILLION VERSUS SEK 0.5 MILLION YEAR AGO

14 Feb 2018

BRIEF-‍Hansa Medical's board has resolved on a directed share issue of SEK 545 mln​

* ‍HANSA MEDICAL'S BOARD OF DIRECTORS HAS RESOLVED ON A DIRECTED SHARE ISSUE OF SEK 545 MILLION​ Source text for Eikon: Further company coverage:

29 Nov 2017

BRIEF-‍Hansa Medical Contemplates Directed Share Issue To Raise About Sek 545 mln​

* ‍HANSA MEDICAL CONTEMPLATES A DIRECTED SHARE ISSUE TO RAISE APPROXIMATELY SEK 545 MILLION​

29 Nov 2017

BRIEF-Hansa Medical Q3 operating loss up at SEK ‍​37.4 mln

* Q3 OPERATING LOSS SEK ‍​37.4 MILLION VERSUS LOSS SEK 27.0 MILLION YEAR AGO

14 Nov 2017

BRIEF-Hansa Medical: sudden death of CEO Göran Arvidson​

* ‍BIRGIT STATTIN NORINDER WILL TAKE OVER ROLE AS CHAIRMAN OF BOARD UNTIL FURTHER NOTICE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

08 Nov 2017

Earnings vs. Estimates